Clincosm LogoSign in Get a demo

relapse

Showing 1 - 25 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alcohol Use Disorder, Stress Reaction, Social Stress Trial in Mannheim (Trier Social Stress Test, Barlab Cue-Exposure,

Not yet recruiting
  • Alcohol Use Disorder
  • +6 more
  • Trier Social Stress Test
  • +2 more
  • Mannheim, Baden-Württemberg, Germany
  • +1 more
Oct 25, 2023

Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)

Not yet recruiting
  • Head and Neck Cancer
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Oct 18, 2023

Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 13, 2023

Migration of Implant, Pain, Postoperative Complications Trial in Van (TEP Group, eTEP Group)

Recruiting
  • Migration of Implant
  • +3 more
  • TEP Group
  • eTEP Group
  • Van, Turkey
    University of Health Science Van Training and Research Hospital
Oct 5, 2023

Migration of Implant, Pain, Postoperative Complications Trial in Van (TEP group, eTEP group)

Recruiting
  • Migration of Implant
  • +3 more
  • TEP group
  • eTEP group
  • Van, Turkey
    University of Health Science Van Training and Research Hospital
Oct 5, 2023

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    Relapse, Orthodontic Retention Trial in Athens (Experimental: Single strand ß-Ti fixed retainer, Experimental: SS fixed

    Recruiting
    • Relapse
    • Orthodontic Retention
    • Experimental: Single strand β-Ti fixed retainer
    • +2 more
    • Athens, Attiki, Greece
      National and Kapodistrian University of Athens, School of Dentis
    Jun 29, 2023

    Relapse Trial in Saint Louis (Computer Aided Design/ Computer Aided Manufacturing Retainers, Lab-based Retainers, Chairside

    Completed
    • Relapse
    • Computer Aided Design/ Computer Aided Manufacturing Retainers
    • +2 more
    • Saint Louis, Missouri
      Saint Louis University
    Jun 13, 2023

    Multiple Myeloma, Relapse, Refractory Trial in Chapel Hill, Winston-Salem, Columbus (Isatuximab, Pomalidomide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • +4 more
    • Chapel Hill, North Carolina
    • +2 more
    Jun 9, 2023

    Relapse Trial in Rohtak (immediate orthodontic retainer delivery, delayed orthodontic retainer delivery.)

    Recruiting
    • Relapse
    • immediate orthodontic retainer delivery
    • delayed orthodontic retainer delivery.
    • Rohtak, Haryana, India
      Post Graduate Institute of Dental Sciences
    May 26, 2023

    Relapse Trial in Rohtak (immediate orthodontic retainer delivery, delayed orthodontic retainer delivery)

    Recruiting
    • Relapse
    • immediate orthodontic retainer delivery
    • delayed orthodontic retainer delivery
    • Rohtak, Haryana, India
      Post Graduate Institute of Dental Sciences
    May 26, 2023

    Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

    Not yet recruiting
    • Relapse
    • +7 more
    • Visakhapatnam, Andhra Pradesh, India
    • +5 more
    May 7, 2023

    Relapse Trial in Rohtak (immediate orthodontic retainer delivery, delayed orthodontic retainer delivery)

    Recruiting
    • Relapse
    • immediate orthodontic retainer delivery
    • delayed orthodontic retainer delivery
    • Rohtak, Haryana, India
      PGIDS
    Nov 8, 2022

    Following Transcutaneous Auricular Neurostimulation to Improve

    Not yet recruiting
    • Opioid Use Disorder
    • Relapse
    • Clinical Outcomes and Questionnaires
    • Rancho Mirage, California
    • +1 more
    Oct 25, 2022

    Malaria, Vivax, Relapse Trial (Primaquine double dose over 14 days, Primaquine single dose over 14 days)

    Not yet recruiting
    • Malaria, Vivax
    • Relapse
    • Primaquine double dose over 14 days
    • Primaquine single dose over 14 days
    • (no location specified)
    Oct 24, 2022

    Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)

    Recruiting
    • Graft-versus-host-disease
    • Relapse
    • Treatment Arm - high dose ATG
    • Control Arm - standard of care
    • Calgary, Alberta, Canada
      Tom Baker Cancer Centre
    Oct 14, 2022

    Disease in Medium Term of Implementation ofSystem of Extended

    Recruiting
    • Eating Disorders
    • +2 more
    • semi-standardized interview
    • care experience questionary
    • Saint-etienne, France
      CHU de SAINT-ETIENNE
    Sep 12, 2022

    Stimulant Use, Relapse, Cognitive Function Trial in Los Angeles (Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion)

    Not yet recruiting
    • Stimulant Use
    • +3 more
    • Contrave 8Mg-90Mg Extended-Release Tablet
    • Bupropion
    • Los Angeles, California
      University of California Los Angeles
    Aug 31, 2022

    Graves Disease, Relapse, Treatment Trial in Nanjing (Methimazole)

    Recruiting
    • Graves Disease
    • +3 more
    • Nanjing, China
      the First Affiliated Hospital of Nanjing Medical University
    Jul 21, 2022

    STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed

    Recruiting
    • Prostate Cancer
    • Relapse
    • Stereotactic salvage radiotherapy for macroscopic prostate bed relapse
    • Florence, Italy
      AOU Careggi Radiation Oncology Unit
    Jul 8, 2022

    Relapse Trial in Bauru (V-bend Bonded Retainer, Vacuum-formed Retainer)

    Completed
    • Relapse
    • V-bend Bonded Retainer
    • Vacuum-formed Retainer
    • Bauru, São Paulo, Brazil
      Bauru Dental School, University of São Paulo
    Jun 28, 2022

    Acute Lymphoblastic Leukemia, CD19 Positive, Relapse Trial in Suzhou (Humanized CD19 CAR-T cells, Humanized CD19 CAR-T cells

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +3 more
    • Humanized CD19 CAR-T cells
    • Humanized CD19 CAR-T cells with CRS suppression technology
    • Suzhou, Jiangsu, China
      The first affiliated hospital of soochow university
    May 18, 2022

    Relapse Trial in Ghent (Twistflex retainer, Orthoflex retainer)

    Active, not recruiting
    • Relapse
    • Twistflex retainer
    • Orthoflex retainer
    • Ghent, Belgium
      University of Ghent
    Feb 10, 2022

    AML/MDS, CMML, Relapse Trial in China, Spain, United States (LP-108, LP-108 and azacitidine)

    Recruiting
    • AML/MDS
    • +5 more
    • Ann Arbor, Michigan
    • +7 more
    Feb 14, 2022

    Lymphomas Non-Hodgkin's B-Cell, Relapse Trial in Tianjin (CD19 CAR T cells)

    Completed
    • Lymphomas Non-Hodgkin's B-Cell
    • Relapse
    • CD19 CAR T cells
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jan 24, 2022